Leads Biolabs hits Hong Kong stock exchange in $189M IPO
Chinese biotech company Leads Biolabs has hit the Hong Kong stock exchange, snagging $189 million through an initial public offering on the HKEX. The Nanjing-based antibody aficionado plans to use the windfall first and foremost on clinical trials, the company said in a July 24 release. About $123 million will go to clinical research, with…